Author | Danielle M. Brander, MD | OncLive

Author | Danielle M. Brander, MD

Articles

Dr. Brander on Targeted Agents in CLL

May 18, 2019

Video

Danielle M. Brander, MD, assistant professor of medicine, Duke Cancer Institute, discusses targeted agents in chronic lymphocytic leukemia (CLL).

Dr. Brander on the Safety and Efficacy of Ibrutinib/Venetoclax in CLL

May 07, 2019

Video

Danielle M. Brander, MD, assistant professor of medicine, Duke Cancer Institute, discusses the safety and efficacy of the combination of venetoclax (Venclexta) and ibrutinib (Imbruvica) in patients with chronic lymphocytic leukemia (CLL).

Dr. Brander Discusses the Frontline Treatment of CLL

August 14, 2018

Video

Danielle M. Brander, MD, assistant professor of medicine, Duke Cancer Institute, discusses the frontline treatment of patients with chronic lymphocytic leukemia.

Dr. Brander on the Treatment Landscape for Patients With High-Risk CLL

July 20, 2018

Video

Danielle Marie Brander, MD, assistant professor of medicine, Duke Cancer Institute, discusses the treatment landscape for patients with high-risk chronic lymphocytic leukemia (CLL).

x